Le Lézard
Classified in: Health
Subject: WOM

Blue Cross & Blue Shield of Mississippi Making Childbirth Safer for Mississippi Women


FLOWOOD, Miss., Sept. 27, 2018 /PRNewswire/ -- The United States has the highest maternal death rate among the world's developed nations and an even higher rate of harm to mothers with more than 50,000 childbirth-related injuries each year.* Since 1990, the number of maternal deaths has risen to 26.4 per 100,000 live births. In Mississippi, that number is 20.8, but even one is one too many. According to a CDC Foundation study, 700 to 900 childbirth-related deaths each year are avoidable, and Blue Cross & Blue Shield of Mississippi (BCBSMS) is taking steps to make childbirth safer for Mississippi women.

Through its Maternity Quality Model, BCBSMS supports hospitals in delivering evidence-based, best-practice care to mothers and babies. The Maternity Quality Model is a statewide quality-improvement initiative in collaboration with Network Hospitals and the Mississippi Perinatal Quality Collaborative (MSPQC) that engages hospitals to reduce maternal and infant harm and death.

As part of its Maternity Quality Model, BCBSMS partnered with the MSPQC to facilitate a series of Network Hospital team training sessions across the state for implementation of clinical best-practice guidelines, known as Maternal Safety Bundles, focused on obstetric hemorrhage (bleeding) and severe hypertension. These bundles were developed by the Alliance for Innovation on Maternal Health (AIM), a national data-driven maternal safety initiative, and are designed to improve the safety of childbirth with a goal of eliminating preventable harm and death. The training sessions brought healthcare professionals from BCBSMS Network Hospitals together to engage in hands-on, simulation-based training scenarios focused on readiness, prevention, treatment and reporting related to obstetric hemorrhage.

"These safety bundles support the goals of reducing gaps in communication, eliminating delays in care and implementing effective treatment strategies through proven methods," said Dr. Sarah Broom, medical director, Blue Cross & Blue Shield of Mississippi.

A study in the American Journal of Obstetrics and Gynecology found hospitals that have adopted AIM's Obstetric Hemorrhage Safety Bundle lowered their rates of severe maternal complications due to hemorrhage by nearly 21 percent.

"We are working to improve maternal outcomes in Mississippi," said Dr. Charlene Collier, director, MSPQC and perinatal health consultant, Mississippi State Department of Health. "These training sessions equip hospitals to ensure their care teams consistently take these evidence-based steps to identify dangerous situations, manage them and, ultimately, save women's lives."

As a result of the BCBSMS Maternity Quality Model, five hospitals in the state have achieved Baby-Friendly Hospital Designation and 91 percent of all hospitals in Mississippi that deliver babies are actively working toward achieving or maintaining this quality designation. Also, nearly all elective deliveries before 39 weeks of gestation have been eliminated, and breastfeeding rates have increased significantly from 49 percent in 2015 to 65 percent in 2018.

Learn more about Blue Cross & Blue Shield of Mississippi's Maternity Quality Model and Women's Health initiative at www.bcbsms.com/womenshealth.

*Source: USA Today (https://www.usatoday.com/in-depth/news/investigations/deadly-deliveries/2018/07/26/maternal-mortality-rates-preeclampsia-postpartum-hemorrhage-safety/546889002/)

SOURCE Blue Cross & Blue Shield of Mississippi


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: